123 related articles for article (PubMed ID: 34499769)
1. HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells.
Lei Z; Xia X; He Q; Luo J; Xiong Y; Wang J; Tang H; Guan T; Tian Y; Xu S; Cui S
Mol Carcinog; 2021 Dec; 60(12):826-839. PubMed ID: 34499769
[TBL] [Abstract][Full Text] [Related]
2. Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis.
Yang ZY; Zhao YW; Xue JR; Guo R; Zhao Z; Liu HD; Ren ZG; Shi M
World J Gastroenterol; 2023 Dec; 29(45):5974-5987. PubMed ID: 38130998
[TBL] [Abstract][Full Text] [Related]
3. HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.
Zhai E; Liang W; Lin Y; Huang L; He X; Cai S; Chen J; Zhang N; Li J; Zhang Q; He Y; Zeng Z; Chen M; Xu L; Peng S
Cell Physiol Biochem; 2018; 47(2):879-892. PubMed ID: 29843139
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase‑associated protein 2.
Duan X; Bai J; Wei J; Li Z; Liu X; Xu G
Mol Med Rep; 2017 Aug; 16(2):2163-2171. PubMed ID: 28627698
[TBL] [Abstract][Full Text] [Related]
5. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.
Wei Z; Jiang X; Liu F; Qiao H; Zhou B; Zhai B; Zhang L; Zhang X; Han L; Jiang H; Krissansen GW; Sun X
Tumour Biol; 2013 Feb; 34(1):181-92. PubMed ID: 23229098
[TBL] [Abstract][Full Text] [Related]
7. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
8. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
Wen Y; Wang K; Yang K
Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
[TBL] [Abstract][Full Text] [Related]
10. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
Huang HC; Way TD; Lin CL; Lin JK
Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
[TBL] [Abstract][Full Text] [Related]
11. Salidroside inhibits the proliferation and migration of gastric cancer cells via suppression of Src‑associated signaling pathway activation and heat shock protein 70 expression.
Qi Z; Tang T; Sheng L; Ma Y; Liu Y; Yan L; Qi S; Ling L; Zhang Y
Mol Med Rep; 2018 Jul; 18(1):147-156. PubMed ID: 29749547
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
13. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.
Geng Q; Liu J; Gong Z; Chen S; Chen S; Li X; Lu Y; Zhu X; Lin HK; Xu D
Mol Cancer; 2017 Apr; 16(1):83. PubMed ID: 28446188
[TBL] [Abstract][Full Text] [Related]
16. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation.
Wang H; Luo J; Tian X; Xu L; Zhai Z; Cheng M; Chen L; Luo S
Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):118994. PubMed ID: 33662413
[TBL] [Abstract][Full Text] [Related]
17. Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism.
Sakai K; Inoue M; Mikami S; Nishimura H; Kuwabara Y; Kojima A; Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Kyoyama H; Moriyama G; Shiibashi M; Seike M; Gemma A; Uematsu K
Thorac Cancer; 2021 Feb; 12(4):491-503. PubMed ID: 33319489
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2).
Song GJ; Leslie KL; Barrick S; Mamonova T; Fitzpatrick JM; Drombosky KW; Peyser N; Wang B; Pellegrini M; Bauer PM; Friedman PA; Mierke DF; Bisello A
J Biol Chem; 2015 Jan; 290(5):2879-87. PubMed ID: 25492869
[TBL] [Abstract][Full Text] [Related]
19. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
Wu YJ; Bond M; Sala-Newby GB; Newby AC
Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
[TBL] [Abstract][Full Text] [Related]
20. The cytomegalovirus protein UL138 induces apoptosis of gastric cancer cells by binding to heat shock protein 70.
Chen W; Lin K; Zhang L; Guo G; Sun X; Chen J; Ye L; Ye S; Mao C; Xu J; Zhang L; Jiang L; Shen X; Xue X
Oncotarget; 2016 Feb; 7(5):5630-45. PubMed ID: 26735338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
